<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK284774" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK284774/" /><meta name="ncbi_pagename" content="Carbonic Anhydrase VA Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Carbonic Anhydrase VA Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Carbonic Anhydrase VA Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/04/02" /><meta name="citation_author" content="Clara van Karnebeek" /><meta name="citation_author" content="Johannes Häberle" /><meta name="citation_pmid" content="25834911" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK284774/" /><meta name="citation_keywords" content="CA-VA Deficiency" /><meta name="citation_keywords" content="CA-VA Deficiency" /><meta name="citation_keywords" content="Carbonic anhydrase 5A, mitochondrial" /><meta name="citation_keywords" content="CA5A" /><meta name="citation_keywords" content="Carbonic Anhydrase VA Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Carbonic Anhydrase VA Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Clara van Karnebeek" /><meta name="DC.Contributor" content="Johannes Häberle" /><meta name="DC.Date" content="2015/04/02" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK284774/" /><meta name="description" content="The four children with carbonic anhydrase VA (CA-VA) deficiency reported to date presented between day two of life and age 20 months with hyperammonemic encephalopathy (i.e., lethargy, feeding intolerance, weight loss, tachypnea, seizures, and coma). Data on long-term follow up are limited (the oldest known patient is age 7 years). Two of the four children showed normal psychomotor development and two showed mild learning difficulties and delayed motor skills. Seven additional children diagnosed with CA-VA deficiency (but not yet published) presented similarly." /><meta name="og:title" content="Carbonic Anhydrase VA Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="The four children with carbonic anhydrase VA (CA-VA) deficiency reported to date presented between day two of life and age 20 months with hyperammonemic encephalopathy (i.e., lethargy, feeding intolerance, weight loss, tachypnea, seizures, and coma). Data on long-term follow up are limited (the oldest known patient is age 7 years). Two of the four children showed normal psychomotor development and two showed mild learning difficulties and delayed motor skills. Seven additional children diagnosed with CA-VA deficiency (but not yet published) presented similarly." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK284774/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ca5a-def/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK284774/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BD130E04161F10000000009C603DD.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK284774_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK284774_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rasa1-rel-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cfc/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK284774_"><span class="title" itemprop="name">Carbonic Anhydrase VA Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: CA-VA Deficiency</div><p class="contrib-group"><span itemprop="author">Clara van Karnebeek</span>, MD, PhD, FCCMG and <span itemprop="author">Johannes H&#x000e4;berle</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK284774_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK284774_ai__"><div class="contrib half_rhythm"><span itemprop="author">Clara van Karnebeek</span>, MD, PhD, FCCMG<div class="affiliation small">Division of Biochemical Diseases<br />Department of Pediatrics<br />BC Children's Hospital &#x00026; Centre for Molecular Medicine and Therapeutics<br />University of British Columbia<br />Vancouver, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.cb.wc@keebenraknavc" class="oemail">ac.cb.wc@keebenraknavc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Johannes H&#x000e4;berle</span>, MD<div class="affiliation small">Division of Metabolism<br />Department of Pediatrics<br />University Children's Hospital Zurich<br />Zurich, Switzerland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="hc.hzu.ipsik@elrebeah.sennahoj" class="oemail">hc.hzu.ipsik@elrebeah.sennahoj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 2, 2015</span>.</p><p><em>Estimated reading time: 15 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ca5a-def.Summary" itemprop="description"><h2 id="_ca5a-def_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The four children with carbonic anhydrase VA (CA-VA) deficiency reported to date presented between day two of life and age 20 months with hyperammonemic encephalopathy (i.e., lethargy, feeding intolerance, weight loss, tachypnea, seizures, and coma). Data on long-term follow up are limited (the oldest known patient is age 7 years). Two of the four children showed normal psychomotor development and two showed mild learning difficulties and delayed motor skills. Seven additional children diagnosed with CA-VA deficiency (but not yet published) presented similarly.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>CA-VA deficiency is suspected in children with neonatal, infantile, or early-childhood metabolic hyperammonemic encephalopathy combined with hyperlactatemia and metabolites suggestive of multiple carboxylase deficiency. The diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with these metabolic findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CA5A</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Admit to the hospital children with insufficient oral intake or refusal to take anything by mouth and/or signs of metabolic decompensation such as encephalopathy. Always provide IV fluids including maintenance glucose plus extra calories via IV lipids, and always monitor plasma ammonia, serum lactate, serum glucose, blood gases, electrolytes, and liver parameters. If ammonia-lowering medication is needed, carglumic acid may be preferable as it has anecdotally shortened the period of hyperammonemia. Other medications such as sodium benzoate would also be reasonable.</p><p><i>Surveillance:</i> Follow up with a metabolic disease specialist every 3-6 months for physical and neurologic examinations. Consider neurodevelopmental testing and measuring of plasma ammonia and amino acids; serum lactate and glucose; blood gases; liver parameters; and urine organic acids.</p><p><i>Agents/circumstances to avoid:</i> Acetazolamide as it inhibits carbonic anhydrase activity.</p><p><i>Evaluation of relatives at risk:</i> When both <i>CA5A</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, it is appropriate to evaluate all sibs in order to identify those who would benefit from prompt treatment when symptoms appear.</p><p><i>Pregnancy management:</i> For an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child: Delivery in hospital with monitoring for several days (physical examination and measurement of serum glucose, blood gases, plasma ammonia, serum lactate, plasma amino acids, and urine organic acids).</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CA-VA deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of inheriting two <i>CA5A</i> pathogenic variants and usually being affected (in some families, asymptomatic [older] sibs with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>CA5A</i> pathogenic variants have been identified), a 50% chance of inheriting one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of inheriting neither pathogenic variant and being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <i>CA5A</i> pathogenic variants in the family are known.</p></div></div><div id="ca5a-def.Diagnosis"><h2 id="_ca5a-def_Diagnosis_">Diagnosis</h2><div id="ca5a-def.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Carbonic anhydrase VA (CA-VA) deficiency should be suspected in children with neonatal, infantile, or early childhood-onset metabolic hyperammonemic encephalopathy (like that observed in the <a href="/books/n/gene/ucd-overview/">urea cycle disorders</a>) combined with hyperlactatemia and metabolites suggestive of multiple carboxylase deficiency.</p><p><b>Abnormal laboratory findings.</b> Outside of acute events, clinical and biochemical parameters often remain normal in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children except for mildly elevated blood lactate and/or the presence of ketonuria [<a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014b.453">van Karnebeek et al 2014b</a>; J H&#x000e4;berle, unpublished data].</p><p>During acute decompensation, the laboratory findings are consistent with dysfunction of all four enzymes to which CA-VA provides bicarbonate as substrate in mitochondria (i.e., carbamoyl phosphate synthetase 1, propionyl CoA carboxylase, pyruvate carboxylase, and 3-methylcrotonyl CoA carboxylase), thereby differentiating CA-VA deficiency from other urea cycle disorders (see <a href="#ca5a-def.Pathophysiology">Pathophysiology</a>). These laboratory findings include:</p><ul><li class="half_rhythm"><div>Significant elevation of plasma ammonia, lactate, and ketones (with concomitant increased urinary ketones); hypoglycemia can also be seen.</div></li><li class="half_rhythm"><div>Complex acid-base status that includes respiratory alkalosis and metabolic acidosis (with decreased bicarbonate and base excess), reflecting the respiratory consequence of hyperammonemia and accumulation of titratable organic acids, respectively</div></li><li class="half_rhythm"><div>Plasma amino acid analysis showing elevation of glutamine and alanine and low-to-normal citrulline</div></li><li class="half_rhythm"><div>Urine organic acid analysis showing elevations of carboxylase substrates and related metabolites: 3-OH propionate, propionylglycine, methylcitrate and lactate, beta-hydroxybutyrate and acetoacetate</div></li></ul><p><b>Normal laboratory findings.</b> While <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> using tandem mass spectrometry (MS/MS) can theoretically detect carboxylase substrates (specifically C3 and C5OH levels as seen in multiple carboxylase deficiency), they were unremarkable in all four individuals reported to date [<a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014b.453">van Karnebeek et al 2014b</a>]. This is likely due to the relatively mild biochemical profile for the carboxylase-related metabolites along with the low <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of acylcarnitine analyses compared to urine organic acids. Note that because of this theoretic finding, individuals with elevated C3 and C5OH should be considered for this disorder in addition to multiple carboxylase deficiency.</p><p>Liver transaminases, albumin, and clotting factors have been normal in the patients reported.</p></div><div id="ca5a-def.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CA-VA deficiency is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the metabolic findings described above and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CA5A</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK284774/table/ca5a-def.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figca5adefTmoleculargenetictestinguse" rid-ob="figobca5adefTmoleculargenetictestinguse">Table 1</a>).</p><p>One <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> strategy is <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>CA5A</i> from leukocyte DNA<i>,</i> followed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</p><div id="ca5a-def.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Carbonic Anhydrase VA Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK284774/table/ca5a-def.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ca5a-def.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ca5a-def.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ca5a-def.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_ca5a-def.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_ca5a-def.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CA5A</i></td><td headers="hd_h_ca5a-def.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_ca5a-def.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10/15 probands</td></tr><tr><td headers="hd_h_ca5a-def.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_ca5a-def.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/15 probands&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ca5a-def.TF.1.1"><p class="no_margin">See <a href="/books/NBK284774/#ca5a-def.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#ca5a-def.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="ca5a-def.TF.1.2"><p class="no_margin">From a total of 15 probands identified with pathogenic variants out of 98 individuals with suggestive phenotypes who were tested [<a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014b.453">van Karnebeek et al 2014b</a>; Authors, unpublished data]</p></div></dd><dt>3. </dt><dd><div id="ca5a-def.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ca5a-def.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="ca5a-def.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014b.453">van Karnebeek et al [2014b]</a></p></div></dd></dl></div></div></div></div></div><div id="ca5a-def.Clinical_Characteristics"><h2 id="_ca5a-def_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ca5a-def.Clinical_Description"><h3>Clinical Description</h3><p>The four children with carbonic anhydrase VA (CA-VA) deficiency reported to date have presented during the newborn period (day 2 of life) or in early childhood (up to age 20 months) with hyperammonemic encephalopathy &#x02013; i.e., lethargy, feeding intolerance, weight loss, tachypnea, seizures, and coma [<a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014b.453">van Karnebeek et al 2014b</a>]. The clinical presentation &#x02013; often triggered by a catabolic state &#x02013; is thus similar to a combination of mild carbamoyl phosphate synthetase 1 deficiency and mild multiple carboxylase deficiency. However, the range of severity on presentation is probably not yet completely understood given the small number of reported cases to date.</p><p>Data on long-term follow up are limited as the oldest known patient is age seven years. Two of the four children reported show normal psychomotor development and two showed mild learning difficulties and delay in motor skills.</p><p>Seven other children who have been diagnosed but not yet published presented similarly.</p></div><div id="ca5a-def.Pathophysiology"><h3>Pathophysiology</h3><p>CA-VA deficiency results in dysfunction of all four enzymes to which CA-VA provides bicarbonate as substrate in mitochondria:</p><ul><li class="half_rhythm"><div>Carbamoyl phosphate synthetase 1 (CPS1) encoded by <i>CPS1</i> (See <a href="/books/n/gene/ucd-overview/">Urea Cycle Disorders Overview</a>.)</div></li><li class="half_rhythm"><div>The three biotin-dependent carboxylases:</div><ul><li class="half_rhythm"><div>Propionyl-CoA carboxylase (PCC) encoded by <i>PCCA</i>and <i>PCCB</i> (See <a href="/books/n/gene/propionic-a/">Propionic Acidemia</a>.)</div></li><li class="half_rhythm"><div>3-methylcrotonyl-CoA carboxylase (3MCC) encoded by <i>MCCC1</i>and<i>MCCC2</i> (OMIM <a href="http://omim.org/entry/210200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">210200</a>, OMIM <a href="http://omim.org/entry/210210" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">210210</a>)</div></li><li class="half_rhythm"><div>Pyruvate carboxylase (PC) encoded by <i>PC</i> (See <a href="/books/n/gene/pdc/">Pyruvate Carboxylase Deficiency</a>.)</div></li></ul></li></ul><p>The authors propose several explanations for the relatively benign clinical course observed in children with carbonic anhydrase VA deficiency: (1) the overlapping function of CA-VB may help prevent deleterious sequelae of reduced CA-VA activity [<a class="bk_pop" href="#ca5a-def.REF.shah.2013.7423">Shah et al 2013</a>]; (2) some bicarbonate is produced via the non-enzymatic reaction, even in the absence of carbonic anhydrases; thus, during stable periods, this may be sufficient for the four different bicarbonate-requiring intra-mitochondrial enzymes.</p></div><div id="ca5a-def.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations remain to be determined. Of note, because of the high rate of <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p>Interestingly, for family 3 reported by <a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014b.453">van Karnebeek et al [2014b]</a> with a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <i>CA5A</i>4kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6 in whom carbonic anhydrase VA was absent in liver, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was not more severe than in the other two families with <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and residual (albeit reduced) carbonic anhydrase VA enzymatic activity.</p></div><div id="ca5a-def.Prevalence"><h3>Prevalence</h3><p>Prevalence is currently unknown. Of note, a high proportion of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in the UK were born to <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Pakistani parents.</p></div></div><div id="ca5a-def.Genetically_Related_Allelic_Dis"><h2 id="_ca5a-def_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>CA5A</i>.</p></div><div id="ca5a-def.Differential_Diagnosis"><h2 id="_ca5a-def_Differential_Diagnosis_">Differential Diagnosis</h2><p>The biochemical profiles of the disorders to be considered in the differential diagnosis of carbonic anhydrase VA (CA-VA) deficiency are summarized in <a class="figpopup" href="/books/NBK284774/table/ca5a-def.T.biochemical_findings_in_cava/?report=objectonly" target="object" rid-figpopup="figca5adefTbiochemicalfindingsincava" rid-ob="figobca5adefTbiochemicalfindingsincava">Table 2</a>.</p><div id="ca5a-def.T.biochemical_findings_in_cava" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Biochemical Findings in CA-VA Deficiency and Other Inborn Errors of Metabolism in the Differential Diagnosis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK284774/table/ca5a-def.T.biochemical_findings_in_cava/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ca5a-def.T.biochemical_findings_in_cava_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" style="text-align:left;vertical-align:middle;">CA-VA Deficiency</th><th id="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Differential Diagnosis</th></tr><tr><th headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3" id="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">PC Deficiency</th><th headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3" id="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple Carboxylase Deficiency</th><th headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3" id="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CPS1 or NAGS Deficiency</th></tr></thead><tbody><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Plasma ammonia</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Serum lactate</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Serum glucose</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl to&#x02193;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02193;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Plasma citrulline</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl to&#x02193;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02193;</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Plasma glutamine</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02193;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Plasma lysine</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HCO3, base excess</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02193;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl to &#x02193;&#x000a0;<sup>1</sup></td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02193;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Urine 3-OH butyrate</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Urine alpha-ketoglutarate</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02193;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nl</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Urine 3-OH propionic acid, propionylglycine, methylcitrate</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nl</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Urine 3-methyl-crotonylglycine, 3-OH isovaleric acid</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191;</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nl</td></tr><tr><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Fatty acids, total &#x00026; free carnitine, acylcarnitine profiles</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nl</td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormal&#x000a0;<sup>2</sup></td><td headers="hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_1_3 hd_h_ca5a-def.T.biochemical_findings_in_cava_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nl</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">&#x02191; = elevated; &#x02193; = decreased; CA-VA = carbonic anhydrase VA; CPS1 = carbamoyl phosphate synthetase 1; NAGS = N-acetyl-glutamate synthase; Nl = normal; PC = pyruvate carboxylase</p></div></dd><dt>1. </dt><dd><div id="ca5a-def.TF.2.1"><p class="no_margin">HCO3 as low as 5 mmol/L and base excess as low as -21 were found in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div></dd><dt>2. </dt><dd><div id="ca5a-def.TF.2.2"><p class="no_margin">Low C0 (free carnitine) and elevated C2, C3, and C5OH</p></div></dd></dl></div></div></div><p><a href="/books/n/gene/pdc/"><b>Pyruvate carboxylase (PC) deficiency</b></a> is characterized in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals by failure to thrive, developmental delay, recurrent seizures, and metabolic acidosis. Three clinical types are recognized:</p><ul><li class="half_rhythm"><div>Type A (infantile form), in which most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children die in infancy or early childhood;</div></li><li class="half_rhythm"><div>Type B (severe neonatal form), in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants have hepatomegaly, pyramidal tract signs, and abnormal movement and die within the first three months of life; and</div></li><li class="half_rhythm"><div>Type C (intermittent/benign form), in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal or mildly delayed neurologic development and episodic metabolic acidosis.</div></li></ul><p>As in patients with PC deficiency, patients with CA-VA have hyperammonemia and hyperlactatemia (+/- hypoglycemia) in common. The differences, however, include the following:</p><ul><li class="half_rhythm"><div>Glutamine levels are elevated in CA-VA deficiency whereas they are normal to decreased in PC deficiency.</div></li><li class="half_rhythm"><div>Citrulline levels are decreased to normal in CA-VA deficiency whereas they are often elevated in PC deficiency.</div></li><li class="half_rhythm"><div>Lysine levels are normal, and 2-&#x003b1;-ketoglutaric acid and other Krebs cycle intermediates are relatively mildly elevated in CA-VA deficiency. In PC deficiency, lysine is elevated and 2-ketoglutarate and other Krebs cycle metabolites are decreased.</div></li></ul><p>The biochemical profiles in the four reported children with CA-VA deficiency support a predominant effect of (secondary) CPS1 deficiency vs PC deficiency.</p><p><b>Multiple carboxylase deficiency (holocarboxylase synthetase and</b>
<a href="/books/n/gene/biotin/"><b>biotinidase deficiency</b></a><b>).</b> If untreated, children with profound deficiency of either of these two enzymes usually exhibit neurologic abnormalities including seizures, lethargy, and hypotonia, which can resemble CA-VA deficiency. The cutaneous abnormalities, ataxia, developmental delay, vision problems, and hearing loss observed in multiple carboxylase deficiency differentiate it clinically from CA-VA deficiency.</p><p>Although biotinidase deficiency and holocarboxylase synthetase (HCS) deficiency share the metabolite profiles of secondary deficiencies of PC, PCC, and 3MCC, the three major differences relative to primary CA-VA deficiency are:</p><ul><li class="half_rhythm"><div>The significantly higher level of PCC and 3MCC metabolites in (even well-controlled) individuals with the two former disorders compared to those with CA-VA deficiency during metabolic decompensation;</div></li><li class="half_rhythm"><div>The presence of secondary CPS1 deficiency (high plasma glutamine and low plasma citrulline) as the (likely) major cause of hyperammonemia in CA-VA deficiency;</div></li><li class="half_rhythm"><div>The presence of acetyl-CoA carboxylase deficiency in HCS deficiency and biotinidase deficiency. Individuals with CA-VA deficiency exhibited normal levels of free fatty acids and total and free carnitine, as well as normal acylcarnitine profiles (data not shown), mostly likely as a result of the activity of the cytosolic acetyl-CoA carboxylase 2 isoform that is not affected by impaired provision of mitochondrial HCO<sub>3</sub><sup>-</sup>.</div></li></ul><p><a href="/books/n/gene/ucd-overview/"><b>Urea cycle defects</b></a><b>.</b> Severe deficiency or total absence of activity of any of the first four enzymes (CPS1, OTC, ASS, ASL) in the urea cycle or the cofactor producer (NAGS) results in the accumulation of ammonia and other precursor metabolites during the first few days of life [<a class="bk_pop" href="#ca5a-def.REF.h_berle.2013.101">H&#x000e4;berle 2013</a>]. Infants with a severe urea cycle disorder are normal at birth but rapidly develop cerebral edema and the related signs of lethargy, poor feeding, hyper- or hypoventilation, hypothermia, seizures, neurologic posturing, and coma. In milder (or partial) deficiencies the elevations of plasma ammonia concentration and symptoms are often subtle and the first recognized clinical episode may not occur for months or decades. In particular, the proximal urea cycle defects (NAGS deficiency and CPS1 deficiency) show the following similarities with CA-VA deficiency:</p><ul><li class="half_rhythm"><div>Hyperammonemia, low plasma citrulline and high plasma glutamine, and no orotic aciduria; and</div></li><li class="half_rhythm"><div>Good response to carglumic acid.</div></li></ul><p>Differences include:</p><ul><li class="half_rhythm"><div>Absence of hyperlactatemia; and</div></li><li class="half_rhythm"><div>Presence of multiple carboxylase deficiency metabolites.</div></li></ul><p><b>Ubiquinol-cytochrome c oxidoreductase core 2 subunit (UQCRC2) deficiency</b> (OMIM <a href="http://omim.org/entry/191329" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">191329</a>) can present with a similar combination of lactic acidosis and episodes of hyperammonemia and hypoglycemia. The pathogenesis of the biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is currently unclear. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>. Diagnosis is by identification of either decreased activity of complex III of the respiratory chain in a skeletal biopsy sample or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>UQCRC2</i>.</p></div><div id="ca5a-def.Management"><h2 id="_ca5a-def_Management_">Management</h2><div id="ca5a-def.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with carbonic anhydrase VA (CA-VA) deficiency, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Measurement of serum lactate, plasma ammonia, serum glucose, blood gases, plasma amino acids, urine ketone bodies, and urine organic acid profiles (during periods of illness; when stable for monitoring, preferably fasting)</div></li><li class="half_rhythm"><div>Liver function parameters (coagulation, albumin, AST, ALT) as acute liver failure can occur in the urea cycle disorders, which are metabolically similar</div></li><li class="half_rhythm"><div>Consideration of:</div><ul><li class="half_rhythm"><div>Brain MRI to define extent of or to exclude brain edema</div></li><li class="half_rhythm"><div>Neurodevelopmental testing</div></li></ul></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="ca5a-def.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>During acute episodes.</b> Admit to the hospital children with insufficient intake or refusal to take anything orally and/or signs of metabolic decompensation such as encephalopathy. The following are recommended:</p><ul><li class="half_rhythm"><div>Always provide IV fluids (with glucose at maintenance doses) and extra calories via IV lipids; restrict protein intake if plasma ammonia is elevated.</div></li><li class="half_rhythm"><div>Always monitor plasma ammonia, serum lactate, serum glucose, blood gases, electrolytes, and liver parameters.</div></li><li class="half_rhythm"><div>Consider administration of carglumic acid (which &#x02013; though not approved yet for this indication &#x02013; enhances CPS1 activity and thus partially compensates for reduced HCO<sub>3</sub><sup>-</sup> resulting from CA-VA deficiency). In the three children who were given carglumic acid during the acute phase, hyperammonemia and clinical symptoms resolved within 12 hours. Without carglumic acid, hyperammonemia persisted longer (i.e., an additional 1-2 days).</div></li><li class="half_rhythm"><div>Other ammonia-lowering medications such as sodium benzoate would also be reasonable.</div></li></ul><p><b>To prevent metabolic decompensation during any catabolic state (viral illness or fasting conditions)</b></p><ul><li class="half_rhythm"><div>Use a sick day formula (extra calories, with limited proteins and extra lipids).</div></li><li class="half_rhythm"><div>Monitor plasma ammonia, serum glucose, blood gases, serum lactate, and plasma amino acids (frequency according to patient's clinical state and physician's expertise).</div></li></ul></div><div id="ca5a-def.Prevention_of_Primary_Manifesta"><h3>Prevention of Primary Manifestations</h3><p>There is no evidence to date that use of a special diet and/or cofactor (zinc) treatment during periods of wellness prevents metabolic decompensations.</p></div><div id="ca5a-def.Surveillance"><h3>Surveillance</h3><p>Follow up with a metabolic disease specialist every three to six months for physical and neurologic examinations. Consider neurodevelopmental testing and measurement of: plasma ammonia and amino acids (to check for chronic hyperammonemia and citrulline deficiency as well as general nutritional state); serum lactate and glucose; blood gases; liver parameters; and urine organic acids.</p></div><div id="ca5a-def.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Acetazolamide should be avoided, as it inhibits carbonic anhydrase activity.</p></div><div id="ca5a-def.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>When both <i>CA5A</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, it is appropriate to evaluate all sibs in order to identify those who would benefit from prompt treatment when symptoms appear.</p><p>Of note, in some families, asymptomatic (older) sibs were found to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>CA5A</i> pathogenic variants through family screening [<a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014b.453">van Karnebeek et al 2014b</a>]. This finding suggests a possible "susceptibility period" during childhood after which individuals with biallelic <i>CA5A</i> pathogenic variants may no longer be at risk of developing signs of CA-VA deficiency.</p><p>See <a href="#ca5a-def.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ca5a-def.Pregnancy_Management"><h3>Pregnancy Management</h3><p><b>For an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother.</b> No pregnancy manaagement issues are known.</p><p><b>For an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child</b></p><ul><li class="half_rhythm"><div>No special management is required during pregnancy.</div></li><li class="half_rhythm"><div>Delivery in hospital is indicated with monitoring for several days (including physical examination and measurement of plasma ammonia, serum lactate, serum glucose, blood gases, plasma amino acids, and urine organic acids).</div></li></ul></div><div id="ca5a-def.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Zinc treatment to enhance residual CA-VA activity is under investigation.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="ca5a-def.Genetic_Counseling"><h2 id="_ca5a-def_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ca5a-def.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Carbonic anhydrase VA (CA-VA) deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ca5a-def.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>CA5A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has:</div><ul><li class="half_rhythm"><div>A 25% chance of inheriting two <i>CA5A</i> pathogenic variants and usually being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Note: In some families, asymptomatic (older) sibs with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>CA5A</i> pathogenic variants have been identified [unpublished];</div></li><li class="half_rhythm"><div>A 50% chance of inheriting one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>;</div></li><li class="half_rhythm"><div>A 25% chance of inheriting neither <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> being unaffected and not a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</div></li></ul></li><li class="half_rhythm"><div>Clinical status of sibs cannot be used to refine their <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> risk as asymptomatic (older) sibs with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>CA5A</i> pathogenic variants have been identified.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with CA-VA deficiency are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CA5A</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>CA5A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="ca5a-def.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>CA5A</i> pathogenic variants in the family.</p></div><div id="ca5a-def.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#ca5a-def.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who have or are at risk of having one or two <i>CA5A</i> pathogenic variants.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ca5a-def.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CA5A</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for CA-VA deficiency are possible. Note: The results of prenatal testing cannot be used to predict with certainty whether or not an individual will be affected as asymptomatic individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>CA5A</i> pathogenic variants have been identified.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing for conditions amenable to treatment, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ca5a-def.Resources"><h2 id="_ca5a-def_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="ca5a-def.Molecular_Genetics"><h2 id="_ca5a-def_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ca5a-def.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Carbonic Anhydrase VA Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK284774/table/ca5a-def.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ca5a-def.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ca5a-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ca5a-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ca5a-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ca5a-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ca5a-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ca5a-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ca5a-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/763" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CA5A</i></a></td><td headers="hd_b_ca5a-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=763" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16q24<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_ca5a-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P35218" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Carbonic anhydrase 5A, mitochondrial</a></td><td headers="hd_b_ca5a-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CA5A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CA5A homepage</a></td><td headers="hd_b_ca5a-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CA5A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CA5A</a></td><td headers="hd_b_ca5a-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CA5A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CA5A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ca5a-def.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ca5a-def.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Carbonic Anhydrase VA Deficiency (<a href="/omim/114761,615751" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK284774/table/ca5a-def.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ca5a-def.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/114761" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">114761</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARBONIC ANHYDRASE VA; CA5A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615751" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615751</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD</td></tr></tbody></table></div></div><p><b>Gene structure.</b> There is one full-length coding transcript (Ensembl identifier ENST00000309893) with a length of 7,567 bp, comprising seven exons. Two other transcripts do not encode any protein product. A <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a>, <i>CA5AP1</i>, has sequences homologous to exons 3-7 and introns 3-6 [<a class="bk_pop" href="#ca5a-def.REF.nagao.1995.477">Nagao et al 1995</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK284774/#ca5a-def.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Variants in <a class="figpopup" href="/books/NBK284774/table/ca5a-def.T.ca5a_pathogenic_variants_disc/?report=objectonly" target="object" rid-figpopup="figca5adefTca5apathogenicvariantsdisc" rid-ob="figobca5adefTca5apathogenicvariantsdisc">Table 3</a> are reported in <a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014a.428">van Karnebeek et al [2014a]</a>.</p><div id="ca5a-def.T.ca5a_pathogenic_variants_disc" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>CA5A</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK284774/table/ca5a-def.T.ca5a_pathogenic_variants_disc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ca5a-def.T.ca5a_pathogenic_variants_disc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.697T&#x0003e;C</td><td headers="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser233Pro</td><td headers="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001739.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001739<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001730.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001730<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.555G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys185=&#x000a0;<sup>2,&#x000a0;3</sup></td></tr><tr><td headers="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.619-3421_774+502del&#x000a0;<sup>4</sup></td><td headers="hd_h_ca5a-def.T.ca5a_pathogenic_variants_disc_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp207_Gln258del</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ca5a-def.TF.3.1"><p class="no_margin">Final nucleotide of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 results in <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> defect.</p></div></dd><dt>2. </dt><dd><div id="ca5a-def.TF.3.2"><p class="no_margin">p.= designates that protein has not been analyzed but no change is expected.</p></div></dd><dt>3. </dt><dd><div id="ca5a-def.TF.3.3"><p class="no_margin"><a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> analysis documented an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4, p.Leu154_Lys185del [<a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014a.428">van Karnebeek et al 2014a</a>].</p></div></dd><dt>4. </dt><dd><div id="ca5a-def.TF.3.4"><p class="no_margin">Deletion of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6 (4,078 bp)</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Carbonic anhydrase VA (CA-VA) comprises 305 amino acids. The two annotated CA5A domains are: (1) the alpha carbonic anhydrase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, which spans from amino acid position 33 to 296; (2) the carbonic anhydrase, alpha-class, conserved site (within the aforementioned domain), which spans from amino acid position 141 to 157. Both domains are important for catalyzing the reversible hydration of carbon dioxide to bicarbonate.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The consequences of the pathogenic variants described by <a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014a.428">van Karnebeek et al [2014a]</a> and <a class="figpopup" href="/books/NBK284774/table/ca5a-def.T.ca5a_pathogenic_variants_disc/?report=objectonly" target="object" rid-figpopup="figca5adefTca5apathogenicvariantsdisc" rid-ob="figobca5adefTca5apathogenicvariantsdisc">Table 3</a> above are:</p><ul><li class="half_rhythm"><div>Homozygous p.Ser233Pro pathogenic variants cause reduced protein stability and reduced enzymatic activity (20% of wild type) with thermal sensitivity;</div></li><li class="half_rhythm"><div>Homozygous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6 causes absence of protein in the liver;</div></li><li class="half_rhythm"><div>Homozygous c.555G&#x0003e;A pathogenic variants disrupt the normal <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> process, leading to skipping of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4. Homozygosity for this <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was observed in one patient with hyperammonemia in the neonatal period (based on Family 2) [<a class="bk_pop" href="#ca5a-def.REF.van_karnebeek.2014a.428">van Karnebeek et al 2014a</a>].</div></li></ul></div><div id="ca5a-def.References"><h2 id="_ca5a-def_References_">References</h2><div id="ca5a-def.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ca5a-def.REF.h_berle.2013.101">H&#x000e4;berle J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. <span><span class="ref-journal">Arch Biochem Biophys. </span>2013;<span class="ref-vol">536</span>:101–8.</span> [<a href="/pubmed/23628343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23628343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ca5a-def.REF.nagao.1995.477">Nagao Y, Batanian JR, Clemente MF, Sly WS. Genomic organization of the human gene (CA5) and pseudogene for mitochondrial carbonic anhydrase V and their localization to chromosomes 16q and 16p. <span><span class="ref-journal">Genomics. </span>1995;<span class="ref-vol">28</span>:477–84.</span> [<a href="/pubmed/7490083" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7490083</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ca5a-def.REF.shah.2013.7423">Shah GN, Rubbelke TS, Hendin J, Nguyen H, Waheed A, Shoemaker JD, Sly WS. Targeted mutagenesis of mitochondrial carbonic anhydrases VA and VB implicates both in ammonia detoxification and glucose metabolism. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2013;<span class="ref-vol">110</span>:7423–8.</span> [<a href="/pmc/articles/PMC3645511/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3645511</span></a>] [<a href="/pubmed/23589845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23589845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ca5a-def.REF.van_karnebeek.2014a.428">van Karnebeek CDM, Shevell MI, Zschocke J, Moeschler J, Stockler S. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. <span><span class="ref-journal">Mol Genet Metab. </span>2014a;<span class="ref-vol">111</span>:428–38.</span> [<a href="/pubmed/24518794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24518794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ca5a-def.REF.van_karnebeek.2014b.453">van Karnebeek CDM, Sly WS, Ross CJ, Salvarinova R, Yaplito-Lee J, Santra S, Shyr C, Horvath GA, Eydoux P, Lehman AM, Bernard V, Newlove T, Ukpeh H, Chakrapani A, Preece MA, Ball S, Pitt J, Vallance HD, Coulter-Mackie M, Nguyen H, Zhang L-H, Bhavsar AP, Sinclair G, Waheed A, Wasserman WW, Stockler-Ipsiroglu S. Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. <span><span class="ref-journal">Am J Hum Genet. </span>2014b;<span class="ref-vol">94</span>:453–61.</span> [<a href="/pmc/articles/PMC3951944/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3951944</span></a>] [<a href="/pubmed/24530203" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24530203</span></a>]</div></li></ul></div></div><div id="ca5a-def.Chapter_Notes"><h2 id="_ca5a-def_Chapter_Notes_">Chapter Notes</h2><div id="ca5a-def.Author_Notes"><h3>Author Notes</h3><p>TIDE (<a href="http://www.tidebc.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.tidebc.org</a>) and Omics2TreatID (<a href="http://www.treatable-id.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.treatable-id.org</a>)</p><p>Clara van Karnebeek, MD, PhD, is a pediatrician-biochemical geneticist who dedicates her research to enhancing early diagnosis and treatment of inborn errors of metabolism to prevent intellectual developmental disabilities.</p><p>Johannes H&#x000e4;berle, MD, is a neonatologist and metabolic pediatrician who specializes in the diagnosis and treatment of urea cycle defects and related disorders with hyperammonemia.</p></div><div id="ca5a-def.Acknowledgments"><h3>Acknowledgments</h3><p>We gratefully acknowledge Casper Shyr, PhD student (University of British Columbia, Vancouver, Canada) for his contributions to the molecular genetics section of this paper.</p></div><div id="ca5a-def.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>2 April 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>8 September 2014 (cvk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK284774</span><span class="label">PMID: <a href="/pubmed/25834911" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">25834911</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rasa1-rel-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cfc/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK284774&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK284774/?report=reader">PubReader</a></li><li><a href="/books/NBK284774/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK284774" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK284774" style="display:none" title="Cite this Page"><div class="bk_tt">van Karnebeek C, Häberle J. Carbonic Anhydrase VA Deficiency. 2015 Apr 2. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK284774/pdf/Bookshelf_NBK284774.pdf">PDF version of this page</a> (418K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ca5a-def.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ca5a-def.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ca5a-def.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ca5a-def.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ca5a-def.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ca5a-def.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ca5a-def.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ca5a-def.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ca5a-def.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ca5a-def.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ca5a-def.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=763[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CA5A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3417936" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3417936" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3417936" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3417936" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301631" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrullinemia Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrullinemia Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Quinonez SC, Thoene JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22649802" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Camacho J, Rioseco-Camacho N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301503" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sloan JL, Carrillo N, Adams D, Venditti CP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=25834911" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=25834911" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042b8539a66ee2bacaeaa6">Carbonic Anhydrase VA Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Carbonic Anhydrase VA Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:39:49-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BD130E04161F10000000009C603DD&amp;ncbi_session=CE8BD130E042B851_2502SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK284774%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK284774&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK284774/&amp;ncbi_pagename=Carbonic Anhydrase VA Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BD130E042B851_2502SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>